or
forgot password

    • cancer clinical trials in shreveport, LA

    • Chemoprevention of Oral Premalignant Lesions
    Pfizer Investigational Site
    Shreveport, Louisiana 71103
    Precancerous Conditions
    A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
    Regional Urology

    Trial Locations
    Regional Urology
    LSUHSC
    Prostate Cancer
    Arsenic Trioxide in Treating Men With Germ Cell Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
    Louisiana State University Health Sciences Center - Shreveport
    Shreveport, Louisiana 71130-3932
    Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer
    S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Ovarian Cancer, Peritoneal Cavity Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences

    Trial Locations
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Christus Schumpert Cancer Treatment Center
    Lung Cancer
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Christus Schumpert Cancer Treatment Center
    Shreveport, Louisiana 71101
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
    Louisiana Health Sciences Center, Department of Medicine, Hematology/Oncology
    Shreveport, Louisiana 71130
    Lymphoma, Non-Hodgkin
    Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
    Louisiana State University Health Sciences Center and VA
    Shreveport, Louisiana 71130
    Lymphoma, Non-Hodgkin
    S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
    Veterans Affairs Medical Center - Shreveport

    Trial Locations
    Veterans Affairs Medical Center - Shreveport
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Leukemia
    Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    Louisiana State University Health Sciences Center
    Shreveport, Louisiana 71130
    Non-small Cell Lung Cancer
    S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
    Veterans Affairs Medical Center - Shreveport

    Trial Locations
    Veterans Affairs Medical Center - Shreveport
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Leukemia
    S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Head and Neck Cancer
    S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Shreveport, Louisiana 71130-3932
    Bladder Cancer, Urethral Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    LSU Health Sciences Center
    Shreveport, Louisiana 71130-3932
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    LSU Health Sciences Center
    Shreveport, Louisiana 71130-3932
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    LSU Health Sciences Center
    Shreveport, Louisiana 71130-3932
    Ovarian Neoplasms
    S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Cervical Cancer
    Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Shreveport, Louisiana 71130-3932
    Head and Neck Cancer
    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Shreveport, Louisiana 71103
    Carcinoma, Renal Cell, Kidney Neoplasms
    S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Shreveport, Louisiana 71130-3932
    Leukemia
    Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Lung Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Cancer Treatment Center at Christus Schumpert St. Mary Place
    Shreveport, Louisiana 71101
    Pancreatic Cancer
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    LSU Health Sciences Center
    Shreveport, Louisiana 71130-3932
    Non-Hodgkin's Lymphoma
    FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
    Veterans Affairs Medical Center - Shreveport

    Trial Locations
    Veterans Affairs Medical Center - Shreveport
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Colorectal Cancer
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Shreveport, Louisiana 71103
    Carcinoma, Renal Cell
    S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Shreveport, Louisiana 71130-3932
    Head and Neck Cancer
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Cancer Treatment Center at Christus Schumpert St. Mary Place
    Shreveport, Louisiana 71101
    Lung Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    LSU Health Sciences Center
    Shreveport, Louisiana 71130-3932
    Non Small Cell Lung Carcinoma
    Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences

    Trial Locations
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Regional Urology, LLC
    Kidney Cancer
    STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
    Overton Brooks, VAMC
    Shreveport, Louisiana 71101
    Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer
    Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
    LSU Health Sciences Center

    Trial Locations
    LSU Health Sciences Center
    Department of Veterns Affairs - Overton Brooks VA Medical Center
    Carcinoma, Non-Small-Cell Lung
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    Christus Schumpert Cancer Treatment Center
    Shreveport, Louisiana 71101
    Head and Neck Cancer
    Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
    Christus Schumpert Cancer Treatment Center
    Shreveport, Louisiana 71101
    Cervical Cancer
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Shreveport, Louisiana 71103
    Colorectal Neoplasms